erythro-5-phosphonooxy-L-lysine

Metabolite details

Identifier

WLPXLNNUXMDSPG-UHNVWZDZSA-N

InChI Key

WLPXLNNUXMDSPG-UHNVWZDZSA-N

IUPAC name

(2S,5R)-2,6-diamino-5-(phosphonooxy)hexanoic acid

Preferred name

erythro-5-phosphonooxy-L-lysine

INN name

—

Synonym

O-Phosphohydroxy-L-lysine

ChEBI

CHEBI:16752

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses
• Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 21)
• Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 10)
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice

Observed in differential profiles

• Control_vs_nsPEF_7_day
• Control_vs_Paramycin
• Sham_vs_UIR
• Sham_vs_UIR
• G1_PBS_vs_G2_DSS